Abstract
The deposit of two proteins in the brain characterizes Alzheimers disease: deposits of β-amyloid protein to form senile plaques and tau protein in neurofibrillary tangles. This review discusses transgenic animals overexpressing normal or mutated tau protein as well as kinases involved in tau hyperphosphorylation. These animals hold a great potential as tools to test the effects of forthcoming therapeutical agents for Alzheimers disease.
Keywords: Tau Pathology, Alzheimers Disease, tau hyperphosphorylation
Mini-Reviews in Medicinal Chemistry
Title: Transgenic Mouse Models with Tau Pathology to Test Therapeutic Agents for Alzheimers Disease
Volume: 2 Issue: 1
Author(s): Felix Hernandez, Filip Lim, Jose J. Lucas, Concepcion Perez-Martin, Franscisco Moreno and Jesus Avila
Affiliation:
Keywords: Tau Pathology, Alzheimers Disease, tau hyperphosphorylation
Abstract: The deposit of two proteins in the brain characterizes Alzheimers disease: deposits of β-amyloid protein to form senile plaques and tau protein in neurofibrillary tangles. This review discusses transgenic animals overexpressing normal or mutated tau protein as well as kinases involved in tau hyperphosphorylation. These animals hold a great potential as tools to test the effects of forthcoming therapeutical agents for Alzheimers disease.
Export Options
About this article
Cite this article as:
Hernandez Felix, Lim Filip, Lucas J. Jose, Perez-Martin Concepcion, Moreno Franscisco and Avila Jesus, Transgenic Mouse Models with Tau Pathology to Test Therapeutic Agents for Alzheimers Disease, Mini-Reviews in Medicinal Chemistry 2002; 2 (1) . https://dx.doi.org/10.2174/1389557023406557
DOI https://dx.doi.org/10.2174/1389557023406557 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclic ADP-ribose (cADPR) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP): Novel Regulators of Ca 2+-Signaling and Cell Function
Current Molecular Medicine Opioid Peptides and Their Glycoconjugates: Structure-Activity Relationships
Current Medicinal Chemistry - Central Nervous System Agents Allosteric Modulators for mGlu Receptors
Current Neuropharmacology Miglustat: Substrate Reduction Therapy for Lysosomal Storage Disorders Associated with Primary Central Nervous System Involvement
Recent Patents on CNS Drug Discovery (Discontinued) Inflammatory Biomarkers for Mood Disorders - A Brief Narrative Review
Current Pharmaceutical Design Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Improved Extraction of Soluble Solids from Some Brazilian and North American Fruits
The Natural Products Journal A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems
Current Pharmaceutical Design Music Therapy for Individuals with Dementia: Areas of Interventions and Research Perspectives
Current Alzheimer Research Hemodynamic Monitoring in the Acute Management of Pediatric Heart Failure
Current Cardiology Reviews Prediction of Affective Responses in Aerobic Exercise Sessions
CNS & Neurological Disorders - Drug Targets Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Editorial: Computational Chemistry and Synthetic Strategy of the Design of Novel Monoamine Oxidase Inhibitors
Combinatorial Chemistry & High Throughput Screening PET Tracers for Serotonin Receptors and Their Applications
Central Nervous System Agents in Medicinal Chemistry Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface
Recent Patents on CNS Drug Discovery (Discontinued) Updating the Chemistry and Biology of Cannabinoid CB2 Receptor – Specific Inverse Agonists
Current Topics in Medicinal Chemistry Neurogenomic Pathway of Autism Spectrum Disorders: Linking Germline and Somatic Mutations to Genetic-Environmental Interactions
Current Bioinformatics Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science The Contrasting Roles of NKT Cells in Tumor Immunity
Current Molecular Medicine Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters